EUVIMEDEUVIMED entdecken
Crossref

Outcomes of Pediatric Liver Transplantation in Glycogen Storage Disease Type 1b—A Single‐Center Experience

Vivek Rajasekaran, Saikat Santra, Chayarani Kelgeri, Lauren Johansen, Suresh Vijay, Sreevidya Sreekantam, Julian Raiman, Anne Daly, Khalid Sharif, Steve Kitchen, Girish Gupte

Pediatric Transplantation · 2024-11 · 28 (7)

DOI: 10.1111/petr.14839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, online erschienen am 30.08.2024. Verfasst von Vivek Rajasekaran und 10 weiteren Autor:innen. Beteiligte Einrichtung: Liver Unit (Including Small Bowel Transplantation), Birmingham Children's Hospital, Birmingham, UK. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type I, Liver Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver transplantation (LT) normalizes fasting tolerance in glycogen storage disease type (GSD) 1b. However, reported outcomes post‐LT with respect to correction of neutropenia, infection risk and growth are varied. Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors have been recently shown to improve neutropenia in GSD1b patients.

Methods

In this single‐center retrospective study, we reviewed all children who underwent LT for GSD1b. Neutropenia, dose of granulocyte colony‐stimulating factor (G‐CSF), unplanned hospital attendance, anthropometrics, graft rejection, survival, and the effects of dapagliflozin were analyzed. Data from protocol biopsies obtained at 1, 5, and 10 years post‐LT and immunosuppression levels were collected.

Results

Eight children (6 female), all on G‐CSF pre‐transplant, underwent cadaveric LT for GSD1b at median age 3.6 years (IQR 3.3–5.1) with mean follow‐up time of 10.3 years (95% CI 7.5–13.1). Neutrophil count and G‐CSF requirement did not improve post‐LT. Although a reduction in unplanned hospital attendance due to infection (0.98 [95% CI 0.76–1.26] vs. 0.49 [95% CI 0.41 to 0.57] per person‐year, p < 0.01) was observed, gastrointestinal complaints and graft dysfunction accounted for a similar hospitalization burden pre‐ versus post‐LT. Body mass index (BMI) reduced post‐LT ( Z ‐score 1.47 [95%CI 0.39–2.23] vs. 0.56 [95% CI −0.74 to 1.45], p = 0.02), with no significant change in height. Although all children and grafts have survived, 75% of recipients developed rejection, despite adequate immunosuppression levels, with two children having been found to have developed significant fibrosis on their 5‐year protocol biopsy. Although dapagliflozin allowed cessation of G‐CSF, no improvement in neutrophil count was observed. Despite this, a reduction in gastrointestinal and infection‐related morbidity was noted following dapagliflozin.

Conclusion

Although LT normalizes fasting tolerance in GSD1b and reduces hospital attendance due to infection, morbidity from infection and gastrointestinal manifestations persist. Children in our cohort experienced high rates of rejection necessitating titration of immunosuppression to balance risk of infection against organ rejection. Future studies should investigate whether early introduction of SGLT2 inhibitors post‐LT impact morbidity in this group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Storage Disease Type ILiver TransplantationHumansFemaleMaleRetrospective StudiesChild, PreschoolChildTreatment OutcomeNeutropeniaFollow-Up StudiesGraft RejectionGranulocyte Colony-Stimulating FactorGraft SurvivalInfant

Substanzen

Granulocyte Colony-Stimulating Factor

Autor:innen und Institutionen

  • Liver Unit (Including Small Bowel Transplantation), Birmingham Children's Hospital, Birmingham, UK.
  • Department of Clinical Inherited Metabolic Disorders, Birmingham Children's Hospital, Birmingham, UK.

Zitieren

APA

Rajasekaran, V., Santra, S., Kelgeri, C., Johansen, L., Vijay, S., Sreekantam, S., Raiman, J., Daly, A., Sharif, K., Kitchen, S., & Gupte, G. (2024). Outcomes of Pediatric Liver Transplantation in Glycogen Storage Disease Type 1b—A Single‐Center Experience. Pediatric Transplantation, 28(7). https://doi.org/10.1111/petr.14839

Vancouver

Rajasekaran V, Santra S, Kelgeri C, Johansen L, Vijay S, Sreekantam S, et al. Outcomes of Pediatric Liver Transplantation in Glycogen Storage Disease Type 1b—A Single‐Center Experience. Pediatric Transplantation. 2024;28(7). doi:10.1111/petr.14839

BibTeX
@article{Rajasekaran2024,
  author = {Rajasekaran, Vivek and Santra, Saikat and Kelgeri, Chayarani and Johansen, Lauren and Vijay, Suresh and Sreekantam, Sreevidya and Raiman, Julian and Daly, Anne and Sharif, Khalid and Kitchen, Steve and Gupte, Girish},
  title = {Outcomes of Pediatric Liver Transplantation in Glycogen Storage Disease Type 1b—A Single‐Center Experience},
  journal = {Pediatric Transplantation},
  year = {2024},
  volume = {28},
  number = {7},
  doi = {10.1111/petr.14839}
}
Kostenlos starten →